In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), Welcure Drugs & Pharmaceuticals has informed that on the recommendation of Nomination & Remuneration Committee, the Board of Directors of the Company in their meeting held on 01st September, 2022 has appointed Vishal Mehra as Chief Financial officer (CFO) of the Company with effect from 01.09.2022 In compliance with SEBI order dated June 14, 2018 to Stock Exchange and further SEBI Circular No. LIST/COMP/14/2018-19 dated June 20, 2018: the company has confirmed that Vishal Mehra has not been debarred from holding the office of the Chief Financial Officer by virtue of any SEBI order or any other authority.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 227.50 |
| Adani Enterprises | 2228.00 |
| Amrapali Industries | 17.36 |
| Rashi Peripheral | 474.40 |
| PDS | 294.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: